Akeso shares plunge 31.8% after FDA rejects ivonescimab application
Published 2 d ago2 sourcesEvidence: Reported
A new STAT-WireScreen index ranks China's most valuable publicly traded biotech companies, with BeOne and Hengrui topping the list. The ranking reflects current market valuations and investor sentiment in China's biotech sector. This is a market-driven snapshot, not a policy or clinical development, and its significance is limited to sector-specific positioning.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Published 2 d ago2 sourcesEvidence: Reported
Published 1 d ago2 sourcesEvidence: Reported
Published 1 d ago2 sourcesEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 1 d ago2 sourcesEvidence: Reported
Published 9 h ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Unknown